Cholinergic Nerve-Driven B-Cell Metabolic Reprogramming Suppresses CD8+ T Cell Cytotoxicity in Gastric Cancer via MEK/ERK-OXPHOS
Abstract Perineural invasion (PNI) is a well recognized adverse prognostic indicator in gastric cancer (GC). However, the specific neural subsets infiltrating the tumor microenvironment and their mechanistic crosstalk with immune cells remain poorly characterized. To address this knowledge gap, we integrated clinicopathological analysis of a 365 patient GC cohort with TCGA STAD data, and demonstrated that PNI independently predicted unfavorable outcomes and featured prominent cholinergic nerve infiltration; moreover, multiplex imaging visualized cholinergic nerve–B cell–CD8⁺ T cell triads in the human GC stroma, offering direct evidence of local neuro immune interplay. In vivo, nerve derived acetylcholine (ACh) accelerated GC progression exclusively through immune dependent routes, without directly stimulating tumor cell proliferation. Functionally, nerve derived ACh elicited B cells to secrete immunosuppressive cytokines IL 10 and TGF β, which subsequently compromised intratumoural CD8⁺ T cell cytotoxicity. Mechanistically, ACh triggered the MEK/ERK cascade in B cells, rewiring lipid metabolism and augmenting oxidative phosphorylation to bioenergetically support the secretion of these suppressive cytokines. Strikingly, MEK inhibition with trametinib completely abrogated the ACh elicited B cell metabolic adaptation, reinstated CD8⁺ T cell effector function, and potently inhibited GC outgrowth. Collectively, our findings uncover a cholinergic driven neuro immune metabolic checkpoint in which neural signals exploit B cell metabolic plasticity to orchestrate GC immune evasion, and we establish that targeting this B cell centric axis with MEK inhibitors offers a mechanistically grounded and clinically actionable strategy to reinvigorate antitumour immunity in gastric cancer.
Authors
- Kaiyi Fu
- Lingxi Lin
- Lishuang Lin
- Feifei Luo (ORCID: https://orcid.org/0000-0002-3834-0188)
- Maolin Ye (ORCID: https://orcid.org/0000-0003-0419-4095)
- Hankun Hao (ORCID: https://orcid.org/0000-0001-6217-2359)
- Zeqin Wang
- Qi Zhou (ORCID: https://orcid.org/0000-0002-5452-3187)
- Jiayue Zheng
- Xiangxi Ye
- Yuting He
- Yaping Wang
- Jun Hong
- Zihao Wang
- Xiaoxuan Su
- Mingye Ma
- Jian Wang
- Yanming Zhang
- Wenweiran Li
- Xinzhu Li
- Wenliang Cui
Institutions
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-10784606/v1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- preprint